CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 51 filers reported holding CONMED CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,486,736 | +7.3% | 2,016,000 | -1.0% | 0.01% | +9.1% |
| Q4 2022 | $2,318,106 | -4.7% | 2,037,000 | -7.8% | 0.01% | 0.0% |
| Q3 2022 | $2,432,000 | -13.9% | 2,209,000 | -5.1% | 0.01% | -8.3% |
| Q2 2022 | $2,824,000 | -92.7% | 2,328,000 | -89.7% | 0.01% | -91.8% |
| Q1 2022 | $38,817,000 | +1.4% | 22,651,000 | -1.4% | 0.15% | +2.1% |
| Q4 2021 | $38,271,000 | +7.0% | 22,961,000 | -0.4% | 0.14% | -8.3% |
| Q3 2021 | $35,765,000 | -4.2% | 23,047,000 | -0.2% | 0.16% | -8.8% |
| Q2 2021 | $37,345,000 | +3.7% | 23,085,000 | +0.5% | 0.17% | -12.8% |
| Q1 2021 | $36,014,000 | +11.6% | 22,981,000 | -0.1% | 0.20% | +4.8% |
| Q4 2020 | $32,262,000 | +26.0% | 23,007,000 | +1.1% | 0.19% | +13.3% |
| Q3 2020 | $25,610,000 | +13.1% | 22,766,000 | +5.7% | 0.16% | +3.1% |
| Q2 2020 | $22,653,000 | +19.5% | 21,531,000 | +6.2% | 0.16% | +7.4% |
| Q1 2020 | $18,959,000 | – | 20,269,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 44,065,000 | $71,296,000 | 7.64% |
| Mohican Financial Management, LLC | 3,000,000 | $4,878,000 | 1.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 9,398,000 | $15,357,000 | 1.40% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $14,433,000 | 0.74% |
| SSI INVESTMENT MANAGEMENT LLC | 6,454,000 | $10,396,000 | 0.67% |
| MACKAY SHIELDS LLC | 38,286,000 | $61,845,000 | 0.58% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,208,000 | $8,417,000 | 0.19% |
| Calamos Advisors LLC | 23,085,000 | $37,345,000 | 0.17% |
| Polar Asset Management Partners Inc. | 10,000,000 | $16,168,000 | 0.17% |
| Calamos Wealth Management LLC | 1,026,000 | $1,660,000 | 0.13% |